Drug & Medication
Table of Contents
BMI View: While Oman is viewed favourably in terms of operating risks, constraints on medicine pricing and the small population will continue to drag down its rewards score. Nevertheless, oil revenues should continue to underpin government’s efforts to provide modern healthcare, while the demand for latest treatments will continue to strengthen on the back of the populations’ preference for branded drugs. Headline Expenditure Proje...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Amrita
+1 718 303 2019
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...
PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as ...
REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%. ...
... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...
... vaccination 1988: before the global polio eradication initiative endemic non-endemic who. Global polio eradication initiative. Available at: http ...
Reportlinker.com © Copyright 2014. All rights reserved.